Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development †

Author： Newman David J.   Cragg Gordon M.  

Publisher： MDPI

E-ISSN： 1660-3397|12|1|255-278

ISSN： 1660-3397

Source： Marine Drugs, Vol.12, Iss.1, 2014-01, pp. : 255-278

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fucoidan as a Marine Anticancer Agent in Preclinical Development

By Kwak Jong-Young  

Marine Drugs, Vol. 12, Iss. 2, 2014-01 ,pp. : 851-870

MDPI

Access to resources Recommend Favorite

Novel Marine Phenazines as Potential Cancer Chemopreventive and Anti-Inflammatory Agents

By Kondratyuk Tamara P.   Park Eun-Jung   Yu Rui   van Breemen Richard B.   Asolkar Ratnakar N.   Murphy Brian T.   Fenical William   Pezzuto John M.  

Marine Drugs, Vol. 10, Iss. 2, 2012-02 ,pp. : 451-464

MDPI

Access to resources Recommend Favorite

Potential Anti-HPV and Related Cancer Agents from Marine Resources: An Overview

By Wang Shi-Xin   Zhang Xiao-Shuang   Guan Hua-Shi   Wang Wei  

Marine Drugs, Vol. 12, Iss. 4, 2014-04 ,pp. : 2019-2035

MDPI

Access to resources Recommend Favorite

Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review

By Kim Gi-Young   Kim Wun-Jae   Choi Yung Hyun  

Marine Drugs, Vol. 9, Iss. 11, 2011-11 ,pp. : 2176-2187

MDPI

Access to resources Recommend Favorite

Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms

By Kumar Sangeetha Ravi   Hosokawa Masashi   Miyashita Kazuo  

Marine Drugs, Vol. 11, Iss. 12, 2013-12 ,pp. : 5130-5147

MDPI

Access to resources Recommend Favorite